CD33 splicing polymorphism determines gemtuzumab ozogamicin response in de novo acute myeloid leukemia: Report from randomized phase III children’s oncology group trial AAML0531

Jatinder K. Lamba, Lata Chauhan, Miyoung Shin, Michael R. Loken, Jessica A. Pollard, Yi Cheng Wang, Rhonda E. Ries, Richard Aplenc, Betsy A. Hirsch, Susana C. Raimondi, Roland B. Walter, Irwin D. Bernstein, Alan S. Gamis, Todd A. Alonzo, Soheil Meshinchi

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'CD33 splicing polymorphism determines gemtuzumab ozogamicin response in de novo acute myeloid leukemia: Report from randomized phase III children’s oncology group trial AAML0531'. Together they form a unique fingerprint.

Medicine & Life Sciences